Sitagliptin phosphateProduct ingredient for Sitagliptin

Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus^Label,4,1,2. The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood sugar^Label,1. Sitagliptin was granted FDA approval on October 16, 2006⁶.